HR-9395-119
Forwarded by Subcommittee to Full Committee by Voice Vote.
Sponsored by Alexandria Ocasio-Cortez (D-NY)
What it does
This bill would require Medicare Advantage organizations to annually report to the federal government whether each enrolled beneficiary signed up through an agent, broker, or third party, and if so, how much that agent or broker was paid and in what form. Starting in 2030, the government would add an indicator to a federal data warehouse tracking these enrollments and publicly post the aggregate compensation data on the Centers for Medicare & Medicaid Services website.
Who benefits
Medicare beneficiaries and their advocates, who would gain visibility into whether enrollment decisions were influenced by broker commissions; researchers and policymakers studying Medicare Advantage marketing practices; CMS oversight staff; and potentially beneficiaries who may be steered toward plans that pay higher commissions rather than plans best suited to their needs, since public reporting could discourage such steering.
Who is hurt
Medicare Advantage organizations and insurance brokers/agents, who would face new administrative and compliance costs to track and report this data; brokers who rely on higher-commission arrangements may see business practices scrutinized or altered; smaller MA organizations or brokerages may bear proportionally higher compliance costs than large insurers with existing data infrastructure.
Supporters argue
Supporters argue that Medicare Advantage marketing has drawn scrutiny from regulators and watchdogs over allegations that some brokers steer beneficiaries toward plans paying higher commissions rather than plans that best fit their medical needs. They contend that public, itemized reporting on enrollment channels and broker compensation would let CMS, researchers, and beneficiaries identify steering patterns and hold plans accountable, similar to existing disclosure requirements in other financial and insurance markets.
Opponents argue
Opponents argue that the new reporting requirements would impose significant administrative burdens and compliance costs on MA organizations and brokers, costs that could ultimately be passed on to beneficiaries through higher premiums or reduced broker availability in underserved areas. They contend that existing CMS marketing rules already address broker compensation and steering concerns, making additional mandatory public disclosure duplicative and potentially exposing sensitive business compensation data without proportionate benefit.
Constitutional context
Congress has broad authority under the Spending Clause and its power to attach conditions to federal healthcare program contracts, since Medicare Advantage organizations voluntarily contract with CMS to participate. This bill raises no significant constitutional question, as it operates through routine contractual reporting conditions rather than compelling private conduct or regulating outside an existing federal program.
Checks and balances
Congress directs the reporting requirement by statute, while the Secretary of Health and Human Services (via CMS) implements the specifics of data collection and public disclosure, with agency rulemaking now subject to independent judicial review of statutory interpretation rather than automatic deference.
Historical precedent
CMS has previously imposed marketing and compensation disclosure rules on Medicare Advantage plans through regulation, though this bill would codify broader public reporting requirements in statute rather than agency rule.